Catalyst Event

Regeneron Pharmaceuticals Inc (REGN) · Other

From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)

4/13/2026, 12:00:00 AM

OtherSentiment: Positive

On April 13, 2026, Regeneron and Telix Pharmaceuticals announced a strategic collaboration to jointly develop and commercialize next-generation radiopharmaceutical therapies for cancer with a $40 million upfront payment

Korean Translation

2026년 4월 13일, 리제네론과 텔릭스 파마슈티컬스의 차세대 방사선 의약품 항암 치료제 공동 개발 및 상용화 전략적 협력 발표(4천만 달러 선지급)함

Related Recent Events

View Full Timeline